A phase 1 trial of Moderna’s COVID-19 vaccine candidate has begun enrolling subjects at the highest dose.

Moderna shared the update on the COVID-19 study alongside news that people in another trial had anti-Zika antibodies after receiving the biotech’s vaccine against that virus. Source: Fierce Biotech 14/4/2020